|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_on1162016699 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160613s2016 nyua ob 001 0 eng |
| 010 |
|
|
|a 2020677394
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d VLY
|d OCLCO
|d N$T
|d EBLCP
|d YDX
|d AGLDB
|d SNK
|d DKU
|d BTN
|d IGB
|d D6H
|d OCLCF
|d VTS
|d G3B
|d SCB
|d S8J
|d S9I
|d STF
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 957772996
|
| 020 |
|
|
|a 9781634856706
|q ebook
|
| 020 |
|
|
|a 1634856708
|
| 020 |
|
|
|z 9781634856492
|q softcover
|
| 035 |
|
|
|a (OCoLC)1162016699
|z (OCoLC)957772996
|
| 050 |
0 |
0 |
|a RL321
|
| 060 |
|
4 |
|a WR 205
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.5/26
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Psoriasis :
|b epidemiology, diagnosis and management strategies /
|c Wilma Lambert, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Dermatology - Laboratory and Clinical Research
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 505 |
0 |
|
|a PSORIASIS: EPIDEMIOLOGY, DIAGNOSIS AND MANAGEMENT STRATEGIES; PSORIASIS: EPIDEMIOLOGY, DIAGNOSIS AND MANAGEMENT STRATEGIES; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: PSORIASIS: A CHALLENGINGMEDICAL CONDITION; ABSTRACT; INTRODUCTION; GENETIC FACTORS; Epidemiology; Diagnosis of Psoriasis; Psoriasis Treatments; Topical Therapy; Topical Corticosteroids; Coal Tar; Vitamin D Analogues; Topical Retinoids; Topical Immuno-Suppressants; Miscellaneous Agents; Anthralin (Dithranol®); Other; Phototherapy; Systemic Treatments; Biological Therapies; CONCLUSION
|
| 505 |
8 |
|
|a Chapter 4: PSORIASIS TREATMENT: TARGETING THE IL-23/TH17 AXISABSTRACT; INTRODUCTION; TH1 PATHWAY; TH17 CELLS; IL-23/TH17 AXIS; THERAPEUTIC STRATEGIES IN PSORIASIS; USTEKINUMAB; SECUKINUMAB; IXEKIZUMAB; BRODALUMAB; CONCLUSION; REFERENCES; Chapter 5: NATURAL HEALTH PRODUCTS FOR PSORIASIS MANAGEMENT; ABSTRACT; INTRODUCTION; CURRENT ETHIOPATHOGENIC CONCEPTS OF PSORIASIS; CONVENTIONAL ANTIPSORIATIC TREATMENTSOF PSORIASIS; TOPICAL TREATMENTS; Corticosteriods; Coal Tar; Dithranol; Vitamin D Analogue (Calcipotriol); Topical Retinoids; PHOTOTHERAPY; SYSTEMIC NON-BIOLOGIC AGENTS; Oral Retinoids
|
| 505 |
8 |
|
|a Methothrexate (MTX)Calcineurin Inhibitors (Cyclosporine); BIOLOGIC AGENTS; PATIENTS SATISFACTION WITH CONVENTIONAL THERAPIES ACCORDING TO WORDLWIDE SURVEYS; PREVALENCE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PSORIATIC PATIENTS; NATURAL HEALTH PRODUCTS FOR PSORIASIS; NATURAL EXTRACTS FROM PLANT ORIGIN; Aloe Vera Extracts; Mahonia Aquifolium Extracts; Picea Mariana Bark Extract; Green the Extract; Neem Bark Extract (Azadirachta Indica); Givotia Rottleriformis Extract; Centella Asiatica Extract; Hamamelis Virginiana Extract; Opoplanax Elatus Extract; Cassia Tora Extracts
|
| 505 |
8 |
|
|a Argemone Mexicana ExtractCissampelos Sympodialis Eichl Extract; Indigo Naturalis Extract; ISOLATED COMPOUNDS FROM PLANTS; Resveratrol; Luteolin; Quercetin; Boswellic Acid; Curcumin; Epigallocatechin Gallate; Capsaicin; Furanocoumarins; NATURAL PRODUCTS FROM ANIMAL ORIGIN; Fish Oil and Omega-3; Whey Protein Extract; Propolis and Bee Venom; FORMULATIONS USING COMBINATION OF NATURAL PRODUCTS FOR PSORIASIS; Psirelax; Traditional Chinese Medicine Preparation; STRENGTHS AND WEAKNESSES OF INVESTIGATIONS WITH NATURAL PRODUCTS FOR PSORIASIS TREATMENT; REFERENCES; INDEX; Blank Page
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Psoriasis.
|
| 650 |
|
0 |
|a Psoriasis
|x Diagnosis.
|
| 650 |
|
0 |
|a Psoriasis
|x Treatment.
|
| 650 |
|
2 |
|a Psoriasis
|
| 650 |
|
6 |
|a Psoriasis.
|
| 650 |
|
6 |
|a Psoriasis
|x Traitement.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Psoriasis
|2 fast
|
| 650 |
|
7 |
|a Psoriasis
|x Treatment
|2 fast
|
| 700 |
1 |
|
|a Lambert, Wilma,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Psoriasis
|d New York : Nova Biomedical, [2016]
|z 9781634856492 (softcover)
|w (DLC) 2016944542
|
| 830 |
|
0 |
|a Dermatology--laboratory and clinical research series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1345799
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4691188
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1345799
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13052486
|
| 994 |
|
|
|a 92
|b IZTAP
|
